Home LiteratureArticle Details
PMID: 9989746 Published · ppublish English Letter Comment

Interferon alfa for chronic hepatitis C infection.

Lancet (London, England) ·Vol. 353 ·No. 9151 ·1999-02-06 ·Pages 499; author reply 500

Kingsley D

Abstract

暂无摘要

MeSH Terms
Antiviral Agents/adverse effects,therapeutic use Hepatitis C, Chronic/therapy Humans Interferon alpha-2 Interferon-alpha/adverse effects,therapeutic use Recombinant Proteins
Chemicals
Antiviral Agents Interferon alpha-2 Interferon-alpha Recombinant Proteins
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Kingsley D
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/S0140-6736(05)75172-2
Published
1999-02-06
Pages
499; author reply 500
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentOn
PMID: 9807989
External Links
PubMed source DOI: 10.1016/S0140-6736(05)75172-2 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2